详细信息

如意珍宝片治疗白脉病相关的慢性肌肉骨骼疼痛的镇痛疗效观察     被引量:1

Analgesic effect of Ruyi Treasure tablets on chronic musculoskeletal pain related to Baimai disease

文献类型:期刊文献

中文题名:如意珍宝片治疗白脉病相关的慢性肌肉骨骼疼痛的镇痛疗效观察

英文题名:Analgesic effect of Ruyi Treasure tablets on chronic musculoskeletal pain related to Baimai disease

作者:宋敏[1];董万涛[1];秦大平[1];梁高峰[2];黄继成[3];俞国河[4]

第一作者:宋敏

机构:[1]甘肃中医药大学附属医院,兰州730000;[2]甘肃宝石花医院,兰州730060;[3]兰州五零四医院,兰州730065;[4]古浪县中医医院,武威733103

第一机构:甘肃中医药大学第二附属医院

年份:2022

卷号:31

期号:20

起止页码:2016

中文期刊名:中国新药杂志

外文期刊名:Chinese Journal of New Drugs

收录:CSTPCD;;Scopus;北大核心:【北大核心2020】;CSCD:【CSCD2021_2022】;

语种:中文

中文关键词:如意珍宝片;白脉病;腰椎间盘突出症;颈椎病;膝骨关节炎;腰椎管狭窄症;疗效观察

外文关键词:Ruyi Treasure tablet;Baimai disease;lumbar disc herniation;cervical spondylosis;knee osteoarthritis;lumbar spinal stenosis;effect observation

摘要:目的:观察如意珍宝片治疗白脉病相关的慢性肌肉骨骼疼痛的临床疗效。方法:选取甘肃省各级医院中符合纳入标准的白脉病相关的慢性肌肉骨骼疼痛患者总计197例,其中腰椎间盘突出症105例、颈椎病36例、膝骨关节炎38例、腰椎管狭窄症18例。研究期间所有患者需要服用如意珍宝片,4片·次^(-1),b id,2周和4周后观察不同类型患者的疗效,包括VAS疼痛评分、NDI颈椎功能评分、Oswestry指数、JOA评分以及WOMAC炎症指数。结果:较治疗前,197例患者VAS评分显著降低,临床疗效有效率为92.39%。进一步观察不同疾病的其他临床指标,颈椎病患者NDI指数显著降低;膝骨关节炎患者WOMAC指数显著降低;腰椎管狭窄症患者JOA指数显著升高、Oswestry指数显著降低;腰椎间盘突出症患者JOA指数显著升高,4种患者各种指数也表现出较高的临床疗效有效率。结论:如意珍宝片能够减轻疼痛,对抗炎性痛、缓解神经性炎症及疼痛,改善各项肢体功能指数及评分,对白脉病相关的慢性肌肉骨骼疼痛有较好的镇痛及功能改善效果,且用药安全。
Objective:To explore the clinical effect of Ruyi Treasure tablets in the treatment of chronic musculoskeletal pain related to Baimai disease.Methods:A total of 197 patients with Baimai disease?related chronic musculoskeletal pain who met the inclusion criteria were selected from the hospitals at all levels in Gansu province,including 105 cases of lumbar disc herniation,36 cases of cervical spondylosis,38 cases of knee osteoarthritis,and 18 cases of lumbar spinal stenosis.During the study,all patients were administered Ruyi Treasure tablets,4 tablets/time,2 times/day,and observed for the efficacy after 2 weeks,including VAS score,NDI cervical function score,Oswestry index,JOA score and WOMAC inflammation index.Results:Compared with previous treatment,the VAS index of 197 patients was significantly reduced.The clinical efficacy rate was 92.39%.After further observation of other clinical indicators of different diseases,it was found that the NDI index of patients with cervical spondylosis decreased significantly,the WOMAC index of patients with knee osteoarthritis decreased significantly,the JOA index of patients with lumbar spinal stenosis increased significantly,the Oswestry index decreased significantly,and the JOA index of patients with lumbar disc herniation increased significantly.Furthermore,various indexes of the four classes of patients also showed higher clinical efficacy.Conclusion:Ruyi Zhenbao tablets improved pain evaluation indicators such as VAS index,anti?inflammatory pain relief of nerve inflammation and pain.It had a good and safe comprehensive analgesic effect on chronic musculoskeletal pain related and function improvement to Baimai disease.

参考文献:

正在载入数据...

版权所有©甘肃中医药大学 重庆维普资讯有限公司 渝B2-20050021-8 
渝公网安备 50019002500408号 违法和不良信息举报中心